Related references
Note: Only part of the references are listed.Real-World Analysis of Outcomes and Economic Burden in Patients with Chronic Kidney Disease with and without Secondary Hyperparathyroidism among a Sample of the Italian Population
Simona Barbuto et al.
NUTRIENTS (2023)
Emerging Imaging Technologies for Parathyroid Gland Identification and Vascular Assessment in Thyroid Surgery A Review From the American Head and Neck Society Endocrine Surgery Section
Amanda Silver L. Karcioglu et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2023)
Systematic Review of the Treatment of Persistent Hyperparathyroidism Following Kidney Transplantation
Milosz Miedziaszczyk et al.
BIOMEDICINES (2023)
Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease
Joshua D. D. Hutcheson et al.
CIRCULATION RESEARCH (2023)
Factors in nephrologists' decision to treat pre-dialysis CKD patients with vitamin D insufficiency and SHPT: A discrete choice experiment
Anand C. Reddy et al.
PLOS ONE (2023)
Comparison of the association intensity of creatinine and cystatin C with hyperphosphatemia and hyperparathyroidism in patients with chronic kidney disease
Byungju Min et al.
SCIENTIFIC REPORTS (2023)
Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: data mining for relationship between vitamin D and parathyroid hormone
M. Gong et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)
Vitamin D as a Shield against Aging
Cristina Fantini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association
Lisa A. Orloff et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)
Machine learning can identify patients at risk of hyperparathyroidism without known calcium and intact parathyroid hormone
Melody L. Greer et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)
Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future
Vincent Brandenburg et al.
NUTRIENTS (2022)
Machine Learning-Based Prediction of Elevated PTH Levels Among the US General Population
Hajime Kato et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines
Marilena Christodoulou et al.
CALCIFIED TISSUE INTERNATIONAL (2021)
Paricalcitol versus Calcitriol plus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis
Zhuolin Zhang et al.
FRONTIERS IN PUBLIC HEALTH (2021)
Physical Determinants of Vitamin D Photosynthesis: A Review
Jonathan J. Neville et al.
JBMR PLUS (2021)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Controversies in Vitamin D: A Statement From the Third International Conference
Andrea Giustina et al.
JBMR PLUS (2020)
Cardiovascular and Cerebrovascular Events After Parathyroidectomy in Patients on Renal Replacement Therapy
Kerstin M. Ivarsson et al.
WORLD JOURNAL OF SURGERY (2019)
Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors
H. H. Malluche et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update
Markus Ketteler et al.
ANNALS OF INTERNAL MEDICINE (2018)
American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, Prevention, and Management in Adults
Lisa A. Orloff et al.
THYROID (2018)
Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies
Pedro Henrique Franca Gois et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention
Michael F. Holick
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2017)
The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases
Rosemary L. Schleicher et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis
Lin Chen et al.
RENAL FAILURE (2016)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: POSTOPERATIVE HYPOPARATHYRODISM - DEFINITIONS AND MANAGEMENT
Brendan C. Stack et al.
ENDOCRINE PRACTICE (2015)
Sunlight and Vitamin D: Necessary for Public Health
Carole A. Baggerly et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2015)
The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism
Kerstin M. Ivarsson et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
Michael F. Holick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
A. Levin et al.
KIDNEY INTERNATIONAL (2007)
Influence of parathyroid mass on the regulation of PTH secretion
E. Lewin et al.
KIDNEY INTERNATIONAL (2006)
Significance of primary hyperparathyroidism in the management of osteoporosis
TFM Saleem et al.
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA (2004)
Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: A 2-year study
CR Parker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism
S Välimäki et al.
KIDNEY INTERNATIONAL (2001)